學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
SIRUM: Scaling a "Tech-for-Good" Medication Donation Platform
內容大綱
Kiah Williams started SIRUM as a Stanford undergraduate alongside her classmates Adam Kircher and George Wang. Nearly two decades later, the medication donation nonprofit was now operating in five states across the country and had helped facilitate medication donations to reach 150,000 uninsured and underinsured patients. SIRUM's technology enabled donors with excess medication supply to donate unexpired, sealed, non-opioid medications to those who needed it most. SIRUM had been largely funded by philanthropic sources and had secured funding through 2025. Williams was now pondering different growth paths for the nonprofit. SIRUM could attempt to grow quickly by expanding into new states or offering a wider range of medications. It could pressure test its pricing model. Or it could build new lines of business related to data, reporting, and compliance. The growth path was unclear. Williams wanted to demonstrate that SIRUM could be a model for social enterprises to succeed and achieve both deep impact and long-term financial stability. How should she build SIRUM's growth strategy?